Since May of 2023, we have been thoughtfully and responsibly managing shipments of the three lowest dose strengths of Wegovy® in an effort to support continuity of care for existing patients while we worked to increase our production capacity.
In January of 2024, we made a commitment to double the amount of the lower dose strengths available in the U.S. market and gradually increase overall supply throughout the year.
As a result of our efforts, we have served over one million U.S. patients with Wegovy® and total weekly prescriptions have more than doubled compared to the beginning of the year. Based on this progress, Novo Nordisk continues to supply all Wegovy® dose strengths to the U.S. market.
Four of the five dose strengths (0.5 mg, 1 mg, 1.7 mg and 2.4 mg) are now available but we will continue to manage shipments of the 0.25 mg starting dose of Wegovy®, in an effort to responsibly initiate patients on treatment, consistent with a focus on continuity of care.
We will do our best to support those who want to start taking Wegovy® but it is important to recognize that overall demand will continue to exceed supply. This means that some patientsmay still have difficulty filling their prescriptions. We will continue to closely monitor market dynamics and prescribing trends.
Obesity is a serious, chronic, and misunderstood disease which affects many people, including friends, colleagues, families, and loved ones and we are confident our actions will help even more people living with obesity in the U.S. – beyond the one million we have already served.
There are five dose strengths of Wegovy® – the first three increase in a stepwise manner leading to the fourth (1.7 mg) and fifth (2.4 mg), maintenance dose strengths (2.4 mg is recommended per thePrescribing Information).
Click herefor an overview of how Wegovy®is made, manufactured and shipped.
Important Guidance: Filling Your Wegovy®Prescription
- We recommend that you contact your pharmacy about refills much earlier than normal. This applies to online and walk-in pharmacies.
- Be specific about the dose strength you need as pharmacies are handling all five Wegovy®dose strengths and may need to order the prescription you are attempting to fill.
- If you are unable to obtain your specific dose strength, we encourage you to try other local pharmacies for availability.
If that is not successful, speak with your healthcareprofessional about your treatment plan to determine the best course of action and options available. Healthcare professionals know their patients' past and current medical history and are best equipped to make clinical recommendations.
At this time, we do not recommend switching to Saxenda® (liraglutide) injection 3 mg as a viable alternate treatment, as we cannot guarantee supply to match the continuous rising demand for weight management medications.
